JP Morgan Chase
AQST icon

JP Morgan Chase’s Aquestive Therapeutics AQST Stock Holding History

JP Morgan Chase’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$260K Sell
64,438
-314,979
-83% -$1.28M ﹤0.01% 5340
2025
Q4 		$2.45M Sell
379,417
-94,162
-20% -$587K ﹤0.01% 3923
2025
Q3 		$2.65M Buy
473,579
+37,607
+9% +$163K ﹤0.01% 3868
2025
Q2 		$1.44M Buy
435,972
+137,956
+46% +$396K ﹤0.01% 4145
2025
Q1 		$864K Buy
298,016
+222,516
+295% +$674K ﹤0.01% 4451
2024
Q4 		$269K Buy
75,500
+30,467
+68% +$140K ﹤0.01% 5347
2024
Q3 		$224K Buy
45,033
+13,199
+41% +$51.4K ﹤0.01% 5355
2024
Q2 		$82.8K Sell
31,834
-70,585
-69% -$236K ﹤0.01% 5622
2024
Q1 		$436K Buy
102,419
+51,363
+101% +$171K ﹤0.01% 4882
2023
Q4 		$103K Buy
51,056
+50,818
+21,352% +$89.8K ﹤0.01% 5720
2023
Q3 		$364 Sell
238
-1,070
-82% -$1.84K ﹤0.01% 6767
2023
Q2 		$2.16K Buy
1,308
+1,123
+607% +$2.03K ﹤0.01% 6322
2023
Q1 		$0 Hold
185
– – ﹤0.01% 6666
2022
Q4 		$0 Sell
185
-2,262
-92% -$2.12K ﹤0.01% 6522
2022
Q3 		$3K Buy
2,447
+716
+41% +$809 ﹤0.01% 6172
2022
Q2 		$1K Sell
1,731
-164,624
-99% -$219K ﹤0.01% 6336
2022
Q1 		$434K Buy
166,355
+23,987
+17% +$70.1K ﹤0.01% 4787
2021
Q4 		$554K Buy
142,368
+23,903
+20% +$120K ﹤0.01% 4760
2021
Q3 		$517K Sell
118,465
-6,946
-6% -$27.2K ﹤0.01% 4700
2021
Q2 		$497K Buy
125,411
+88,342
+238% +$353K ﹤0.01% 4699
2021
Q1 		$193K Sell
37,069
-1,794
-5% -$9.54K ﹤0.01% 5162
2020
Q4 		$208K Buy
38,863
+25,347
+188% +$152K ﹤0.01% 4795
2020
Q3 		$60K Buy
13,516
+4,446
+49% +$29.1K ﹤0.01% 4891
2020
Q2 		$44K Sell
9,070
-404,892
-98% -$1.86M ﹤0.01% 4864
2020
Q1 		$907K Buy
413,962
+95,381
+30% +$362K ﹤0.01% 3455
2019
Q4 		$1.85M Buy
318,581
+206,778
+185% +$1.08M ﹤0.01% 3435
2019
Q3 		$356K Buy
111,803
+89,042
+391% +$334K ﹤0.01% 4338
2019
Q2 		$93K Buy
22,761
+20,014
+729% +$102K ﹤0.01% 4960
2019
Q1 		$19K Buy
2,747
+1,412
+106% +$9.89K ﹤0.01% 5417
2018
Q4 		$8K Buy
1,335
+125
+10% +$1.58K ﹤0.01% 5464
2018
Q3 		$21K Buy
+1,210
New +$19.9K ﹤0.01% 5408

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase's AQST Position: Q1 2026 in Review

JP Morgan Chase reduced its Aquestive Therapeutics (AQST) stake by 83% in Q1 2026, selling an estimated $1.28M and leaving 64,438 shares worth $260K. The position accounts for ﹤0.01% of the portfolio, ranked #5340.

JP Morgan Chase first reported a position in AQST in Q3 2018 and has held it in 31 quarters since. The position peaked at $2.65M in Q3 2025. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • JP Morgan Chase held 64,438 shares of Aquestive Therapeutics worth $260K as of Q1 2026.
  • JP Morgan Chase sold 314,979 Aquestive Therapeutics shares in Q1 2026, an estimated $1.28M.
  • Aquestive Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5340 holding.
  • JP Morgan Chase first reported a position in Aquestive Therapeutics in Q3 2018 and has held it in 31 quarters since.
  • JP Morgan Chase's Aquestive Therapeutics position peaked at $2.65M in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.